Ilaris (canakinumab)

canakinumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ilaris (canakinumab), covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD [Phase 3]